Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

There's Much to Watch This Week

It is good to be filling in for Doug Kass today, here at the Daily Diary, as September comes to a close. Stocks will look to bounce back from an off performance last week. Equities accelerated their pullback on Friday when the administration floated...

Markets Become Rocky, Especially for IPOs

Cracks are appearing in some high-beta parts of the market, and a few recent initial public offerings have been pulled or haven't fared well after issuance.

3 Concerns for Investors as We Head Into the Fourth Quarter

U.S./China trade, Iran, and Brexit top the list.

Consider These 3 Small-Cap Stocks

We look at a few overlooked and undervalued small cap concerns.

3 Small-Cap Names in the Red-Hot Housing Sector That Are Worth a Look

Beazer Homes USA, Taylor Morrison Home Corp. and Hooker Furniture is a trio to consider.

3 Small Biotechs With Favorable Risk Vs. Reward Profiles

BioDelivery Sciences International, Chiasma Inc. and TherapeticsMD all feature promising treatments.

Let's See Whether Small-Cap Resurgence Continues

The Russell 2000 had a strong week last week, but whether smaller names can outperform their large-cap brethren going forward remains to be seen.

2 Downtrodden Small Biotechs That Are Showing Signs of Life

T2 Biosystems and Replimune Group have spurted higher in the last couple weeks, with the former doubling in value on encouraging news.

That's a Wrap

The market strengthened some since our last update. Small biotechs continued to be one of the strongest parts of the rally as the SPDR Biotech ETF is up some 2% on the day. T. Boone Pickens, one of the original corporate raiders, passed away at 91 t...

This Market Is Green

Indices have not changed much since my last post and the market remains solidly in the green. Not a big rise, but a steady one. Strength in the market continues to be mostly in the small cap names as it has for most of the last week. The Russell 200...

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight